← FDA DRUG APPROVALS

FDA ANDA · ANDA220016

MESALAMINE

Sponsor: KLM LABS PVT

APPLICATION
ANDA220016
TYPE
ANDA
ORIGINAL APPROVAL
2026-03-31
LATEST ACTION
2026-03-31
ROUTE
RECTAL
DOSAGE FORM
ENEMA
MARKETING STATUS
Prescription

Products

MESALAMINEPrescription
MESALAMINE 4GM/60ML · ENEMA · RECTAL

Approval history

2026-03-31UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →